CXCR5 and breast cancer: Here, a subpopulation of CXCR5+PD‐1+ cytotoxic T cells was identified with high TIM‐3, ICOS, and CD45RO expression in the lymph nodes from breast cancer patients but showed limited association with the clinical features of the patients.